Lamotrigine for neuroprotection in secondary progressive multiple sclerosis: a randomised, double-blind, placebo-controlled, parallel-group trial : The Lancet Neurology
Links shared publicly online about this topic.
- 1,112total visits
Lamotrigine for neuroprotection in secondary progressive multiple sclerosis: a randomised, double-blind, placebo-controlled, parallel-group trial : The Lancet Neurology
Lamotrigine for neuroprotection in secondary progressive multiple sclerosis: a randomised, double-blind, placebo-controlled, parallel-group trial. By - Raju Kapoor FRCP, Julian Furby MRCP, Thomas H...
View full resource at thelancet.com
Tags: Neurology, Multiple Sclerosis, Seizure Medication, Lamictal, Epilepsy Medication
Most Recently Shared on June 7, 2010 at 9:22 am By:
Lamotrigine for secondary progressive multiple sclerosis http://bit.ly/dgJmGI
Lamotrigine for neuroprotection in secondary progressive multiple sclerosis: a randomised, double-blind, placebo-controlled, parallel-group trial : The Lancet Neurology
thelancet.com — “Lamotrigine for neuroprotection in secondary progressive multiple sclerosis: a randomised, double-blind, placebo-controlled, parallel-group trial. By - Raju Kapoor FRCP, Julian Furby MRCP, Thomas H...” View full resource at thelancet.com
Most Recently Shared on June 7, 2010 at 12:53 pm By:
Lamotrigine for neuroprotection in secondary progressive multiple sclerosis: a randomised, double-blind, placebo .... http://bit.ly/dyIQlH
Advertisement
